Investigation of the in vitro performance difference of drug-Soluplus® and drug-PEG 6000 dispersions when prepared using spray drying or lyophilization
Purpose: To evaluate the physicochemical and in vitro characteristics of solid dispersions using BCS II model drugs with Soluplus® and one of its component homopolymers, PEG 6000. Methods: Nifedipine (NIF) and sulfamethoxazole (SMX) of 99.3% and 99.5% purity, respectively, were selected as BCS II mo...
Main Authors: | Mohammad A. Altamimi, Steven H. Neau |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2017-03-01
|
Series: | Saudi Pharmaceutical Journal |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S1319016416301050 |
Similar Items
-
The Effect of Tween 20, 60, and 80 on Dissolution Behavior of
Sprionolactone in Solid Dispersions Prepared by PEG 6000
by: Jafar Akbari, et al.
Published: (2015-09-01) -
Characterization and Pharmacokinetic Study of Aprepitant Solid Dispersions with Soluplus®
by: Jinwen Liu, et al.
Published: (2015-06-01) -
Characterization of Nanoparticles Using DSPE-PEG2000 and Soluplus
by: Rina Takayama, et al.
Published: (2020-07-01) -
Study of gliclazide solid dispersion systems using PVP K-30 and PEG 6000 by solvent method
by: Febriyenti Febriyenti, et al.
Published: (2019-01-01) -
Preparation of Solid Dispersions of Simvastatin and Soluplus Using a Single-Step Organic Solvent-Free Supercritical Fluid Process for the Drug Solubility and Dissolution Rate Enhancement
by: Uttom Nandi, et al.
Published: (2021-08-01)